Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Norway
/
Healthcare
Create a narrative
Medistim Community
OB:MEDI Community
1
Narratives
written by author
0
Comments
on narratives written by author
2
Fair Values set
on narratives written by author
Create a narrative
Medistim
Popular
Undervalued
Overvalued
Community Investing Ideas
Medistim
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
R&D Investments May Impact Margins, But New Products Could Boost Future Revenue
Key Takeaways Significant investments in R&D and product launches might strain profitability if they don't lead to expected revenue gains. Expansion and strategic goals face challenges, which could impact net margins and future revenue growth if not effectively managed.
View narrative
NOK 172.00
FV
18.6% overvalued
intrinsic discount
7.46%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
9 days ago
author updated this narrative
Your Valuation for
MEDI
MEDI
Medistim
Your Fair Value
NOK
Current Price
NOK 204.00
44.5% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
820m
2015
2018
2021
2024
2025
2027
2030
Revenue NOK 819.6m
Earnings NOK 166.8m
Advanced
Set Fair Value